Activity Overview
Health-system pharmacists are an integral part of the interdisciplinary team that is critical in the management of pain. Increasingly involved in many aspects of patient
care, these pharmacists are uniquely positioned to contribute substantially to pain
management throughout the continuum of care, from acute treatment through chronic
pain management. This educational activity will focus on the critical dilemmas that
are woven within treatment decisions throughout the pain continuum. Health-system
pharmacists will be educated on: (1) how to distinguish acute from chronic pain; (2)
how to choose optimal treatment strategies; and (3) when to safely and effectively
utilize opiates in their patients’ pain management regimes. Through dynamic presentations
and interactive cases, attendees will walk away with the skills to apply this
current information to their clinical practice.
Agenda
| 11:30 - 11:45 AM |
Conference Goals/Pre-Test
J. Richard Brown, PharmD, FASHP |
| 11:45 - 12:00 PM |
The Pain Continuum: From Acute Treatment to Chronic Management
J. Richard Brown, PharmD, FASHP |
| 12:00 - 12:40 PM |
Treatment of Pain: Current Concepts
Robert L. Barkin, PharmD, MBA, FCP, DAAPM |
| 12:40 - 1:15 PM |
Managing Pain with Opiates: Strategies for
Health-System Pharmacists
Bruce R. Canaday, PharmD, FASHP, FAPhA |
| 1:15 - 1:30 PM |
Closing Comments/Post-Test and Q&A |
Goal
To provide health-system pharmacists attending the 44th ASHP Midyear Clinical Meeting and
Exhibition with an enhanced understanding of the etiology and current pharmacologic treatment of acute
and chronic pain, and to impart that knowledge to the interdisciplinary team for optimal patient outcomes.
Intended Audience
This activity is designed for pharmacists attending the 44th ASHP Midyear
Clinical Meeting and Exhibition. No prerequisites required.
Learning Objectives
The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CPE activity. Upon the conclusion of this activity,
the participant should be able to:
- EXPLAIN the clinical, psychological, and economic impact of acute pain, with
particular attention to special populations (ie, elderly).
- REVIEW current and emerging pharmacologic treatments for acute pain,
including efficacy, mechanisms of action, and adverse effects including
addiction.
- IDENTIFY the role of the pharmacist in the interdisciplinary team for optimal
management of acute pain.
- RECOGNIZE the economic impact of inadequate pain management in the
health-system setting and formulate strategies to optimize patient and health-system
outcomes.
Accreditation Statement
The University of Tennessee College of Pharmacy is accredited by the
Accreditation Council for Pharmacy Education to provide continuing education for pharmacists.
Credit Designation Statement
This application-based activity is sponsored by the University of
Tennessee College of Pharmacy who is accredited by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education. Successful completion of this application-based educational activity will provide 2.0 contact hours credit (0.2 CEUs). A statement
of CPE credit will be mailed within 4 weeks following successful completion of the educational
activity. Successful completion includes attending the session, signing the attendance sheet, and completion
of the educational activity evaluation form. ACPE Program #064-000-09-207-L01-P.
Faculty
J. Richard Brown, PharmD, FASHP (Chair)
Professor, Clinical Pharmacy
University of Tennessee
Memphis, Tennessee
Robert L. Barkin, PharmD, MBA, FCP, DAAPM
Professor, Rush Medical College
Faculty of Anesthesiology, Family Medicine, and Pharmacology
Rush University Medical Center
Clinical Pharmacologist, Northshore University Health System—Skokie, Evanston Hospitals, Pain Centers, and The Department of Anesthesiology
Chicago, Illinois
Bruce R. Canaday, PharmD, FASHP, FAPhA
Clinical Professor and Vice-Chair
Division of Pharmacy Practice and Experiential Education
University of North Carolina Eshelman School of Pharmacy
Chapel Hill, North Carolina
Policy on Faculty and Provider Disclosure
It is the policy of The University of Tennessee
College of Pharmacy that the faculty and provider disclose real or apparent conflicts of interest relating to
the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs
or devices during the presentation(s). Detailed disclosures will be made in the course handout materials.
Americans with Disabilities Act (ADA)
The University of Tennessee College of Pharmacy fully
complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if
you have any special needs.
Grievance Policy
A participant, sponsor, faculty member, or other individual wanting to file a grievance
with respect to any aspect of an educational activity sponsored or cosponsored by The University of
Tennessee College of Pharmacy may contact the Associate Dean for Continuing Education in writing. The
grievance will be reviewed and a response will be returned within 45 days of receiving the written statement.
If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level review.
Fee Information
There is no fee for this educational activity.
|